Novel Endocrine Therapy Agents in ER-Positive, HER2-Negative Breast Cancer

H&O  What types of novel endocrine therapies are being developed for use in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer? EH  […]

The Optimal Duration of Endocrine Therapy in Hormone Receptor–Positive Breast Cancer

H&O  Which patients are eligible for endocrine therapy alone vs endocrine therapy plus chemotherapy? GS  Historically, we based this decision on the TNM (tumor, node, metastasis) […]